Results 51 to 60 of about 30,075 (198)

ANZTCT cytomegalovirus practice survey for allogeneic haemopoietic stem cell transplant and cellular therapy recipients in Australia and New Zealand

Internal Medicine Journal, EarlyView.
Abstract Background Despite pre‐emptive treatment (PeT), cytomegalovirus (CMV) disease and reactivation remain a clinical concern. In Australia and New Zealand (ANZ), variability exists in the management of CMV for haematopoietic stem cell transplantation (HSCT) recipients.
Andrea Henden, Lynette Chee, Julia Clark, Rachel Conyers, Julian Cooney, Richard Doocey, David Gottlieb, Tim Prestidge, Madeleine Powys, Philip Selby, Gaurav Sutrave, Eric Wong, Michelle K. Yong, Nada Hamad   +13 more
wiley   +1 more source

Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient

, 2005
International audienceWe describe the emergence of a new ganciclovir resistance mutation in the UL97 gene of human cytomegalovirus, deletion of codon 601, after valaciclovir and short-term ganciclovir therapy following kidney transplantation. Its role in
Guigonis, Vincent, Mazeron, Marie-Christine, Dehee, Axelle, Denis, François, Fillet, Anne-Marie, Champier, Gaël, Mertens, Thomas, Michel, Detlef, Bensman, Albert, Alain, Sophie, Hantz, Sébastien   +10 more
core   +1 more source

Effect of individualized therapy for AIDS patients with cytomegalovirus retinitis in intravitreal ganciclovir injections [PDF]

International Journal of Ophthalmology, 2019
The effect of intravitreal ganciclovir injection combined with intravenous infusion on acquired immune deficiency syndrome (AIDS) patients with cytomegalovirus retinitis (CMVR) was investigated.
Lian-Yong Xie, Chao Chen, Wen-Jun Kong, Kui-Fang Du, Chun-Gang Guo, Hong-Wei Dong, Wen-Bin Wei   +6 more
doaj   +1 more source

The Association of Pretransplant CD4 Count With Post‐Kidney Transplant Infectious Outcomes Among Persons With HIV

Transplant Infectious Disease, EarlyView.
In this multi‐center study comparing persons with HIV with pre‐kidney transplant CD4 < 350 cells/µL to those with ≥ 350 cells/µL, we found no difference in relative risk of infection in the first year‐post kidney transplant, 5‐year graft survival, and 5‐year overall survival.
Rebecca H. Burns, Sara Booth, Christin Rogers Marks, Christine M. Durand, Jonathan Hand, Maheen Z. Abidi, Maricar Malinis, Brittany Barnaba, Martha Pavlakis, Douglas Krakower, Carolyn D. Alonso, Audrey Le‐Mahajan   +11 more
wiley   +1 more source

Preemptive ganciclovir for mechanically ventilated patients with cytomegalovirus reactivation

, 2021
International audienceBackground: The effect of cytomegalovirus (CMV) reactivation on the length of mechanical ventilation and mortality in immunocompetent ICU patients requiring invasive mechanical ventilation remains controversial.
Jean Chastre, Toufik Kamel, Allardet-Servent, Jérôme, Lu, Qin, Laurent Papazian, Jung, Boris, Nadia Aissaoui, Bourenne, Jérémy, Jaber, Samir, Schwebel, Carole, Anderson Loundou, Leone, Marc, Penot-Ragon, Christine, Zandotti, Christine, Sophie Cayot-Constantin, Cayot-Constantin, Sophie, Loundou, Anderson, Jérôme Allardet-Servent, Qin Lu, Charles-Edouard Luyt, Forel, Jean-Marie, Karine Baumstarck, Boris Jung, Luyt, Charles-Edouard, Christine Zandotti, Souweine, Bertrand, Hraiech, Sami, Sami Hraiech, Kamel, Toufik, Papazian, Laurent, Baumstarck, Karine, Christine Penot-Ragon, Aissaoui, Nadia, Chastre, Jean, Carole Schwebel, Jean-Marie Forel, Samir Jaber, Jérémy Bourenne, Marc Leone, Bertrand Souweine   +39 more
core   +1 more source

Clinical Effectiveness of the Recombinant Zoster Vaccine for Preventing Herpes Zoster in Individuals With Kidney Transplants: A Retrospective Cohort Study

Transplant Infectious Disease, EarlyView.
In this retrospective cohort of kidney transplant recipients, no herpes zoster cases occurred during 398 vaccinated person‐years, compared with 78 cases (16.4 per 1000 person‐years) among unvaccinated recipients. These findings support a protective association of the recombinant zoster vaccine (RZV) and reinforce current recommendations for ...
Kyungsup Kwon, So Yun Lim, Euijin Chang, Seongman Bae, Hyunwook Kwon, Jiwon Jung, Min Jae Kim, Sung Shin, Yong Pil Chong, Young Hoon Kim, Sang‐Ho Choi, Sang‐Oh Lee, Sung‐Han Kim   +12 more
wiley   +1 more source

Effect of a Histone Demethylase Inhibitor on Equine Herpesvirus-1 Activity In Vitro

Frontiers in Veterinary Science, 2018
Equine herpesvirus type 1 (EHV-1) is a ubiquitous and highly contagious pathogen that causes a range of disease severities with outbreaks of notable economic impact.
Rebecca L. Tallmadge, Emilija Žygelytė, Gerlinde R. Van de Walle, Thomas M. Kristie, M. Julia B. Felippe   +4 more
doaj   +1 more source

Letermovir in Refractory and Resistant CMV After Lung Transplantation: Therapeutic Potential and Emergence of Resistance

Transplant Infectious Disease, EarlyView.
Letermovir use for active R/R CMV infection was associated with treatment‐emergent resistance in approximately one‐third of patients, particularly in those with high baseline viral loads and delayed virological response. These findings support careful patient selection, close virological monitoring, and early resistance testing.
Tobias Veit, Stefan Trost, Teresa Kauke, Nina Engels, Gabriela Leuschner, Michael Gerckens, Carlo Mümmler, Sebastian Michel, Michael Zoller, Valeria Hackemann, Jürgen Behr, Nikolaus Kneidinger   +11 more
wiley   +1 more source

Rezidivprophylaxe der Zytomegalievirus-Uveitis mit topischem Ganciclovir

, 2019
PURPOSE ytomegalovirus (CMV) can cause recurrent or chronic hypertensive anterior uveitis in immunocompetent patients. Antiviral treatment options include topical ganciclovir or systemic valganciclovir.
Hänsli, Christof, Meier, Fabio, Barthelmes, Daniel, Böni, Christian   +3 more
core   +1 more source

Determination of ganciclovir in lung transplant recipients [PDF]

Charles University Faculty of Pharmacy in Hradec Králové Department of Biochemical Sciences Candidate: Bc. Filip Hrach Supervisor: prof. Ing. Barbora Szotáková, Ph.D. Consultant: doc. Ing. Eva Klapková, Ph.D.
Hrach, Filip
core   +1 more source